Sign Up to like & get
recommendations!
0
Published in 2017 at "Experimental hematology"
DOI: 10.1016/j.exphem.2016.09.001
Abstract: The clinical benefits of hydroxyurea (HU) treatment in patients with sickle cell disease (SCD) are due largely to increased γ-globin expression. However, mechanisms that control γ-globin expression by HU in erythroid progenitors are incompletely understood. Here,…
read more here.
Keywords:
octn1;
expression erythroid;
expression;
globin expression ... See more keywords